26 Jun 2023 Flen Health receives 1.7 million grant from VLAIO for groundbreaking research on recombinant engineering of wound-healing enzymes Member news
21 Jun 2023 argenx announces U.S. Food and Drug Administration approval of VYVGART Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) injection for subcutaneous use in generalized myasthenia gravis Member news
20 Jun 2023 argenx initiates second cohort of Phase 2 ARDA study of empasiprubart in multifocal motor neuropathy Member news
16 Jun 2023 Biocartis announces planned operational reorganization and cost reduction program Member news
16 Jun 2023 Galapagos appoints Thad Huston as Chief Financial Officer and Chief Operating Officer Member news
16 Jun 2023 Sequana Medical wins Best Technology Award for alfapump® at European Mediscience Awards Member news
16 Jun 2023 With the platform Startup.Flanders, Flanders claims its place among international start-up ecosystems Member news
16 Jun 2023 Confo Therapeutics enters into research collaboration for GPCR-targeting antibody discovery with AbCellera Member news
13 Jun 2023 Galapagos appoints Dr. Susanne Schaffert as non-executive independent Director to its Board Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
